DJO sued over ReAble deal
This article was originally published in The Gray Sheet
Shareholders of orthopedic device maker DJO file class action lawsuit in San Diego state court Aug. 31 seeking an injunction on the company's pending $1.6 billion sale to ReAble Therapeutics, claiming that the price is inadequate. The complaint alleges that DJO and its board approved the sale in July without shopping the firm to other potential buyers or fully informing themselves of its value (1"The Gray Sheet" July 23, 2007, p. 6). DJO says it will "vigorously oppose" the allegations, although it expects additional suits with similar claims
You may also be interested in...
ReAble Therapeutics agreed July 16 to buy DJO for about $1.6 billion in a deal that will give the privately held firm a substantial stake in the bracing and soft goods orthopedic market and complement its current strength in electrotherapy pain management
Policy experts predicted how the incoming Biden administration will handle health care issues at a recent Alliance for Health Policy webinar. Rachel Nuzum, VP of state and federal policy at The Commonwealth Fund, said telehealth could be a priority.
The China National Biotec Group has filed the first application in China for the broad use of a COVID-19 vaccine, days after the national regulatory agency released review guidelines for the conditional approval of such products.